Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock

Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock CaS-POL

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support. It is hypothesized that the treatment and outcome of cardiogenic shock, including mechanical circulatory support, are currently poor in Poland and should be improved. Unfortunately, without status quo data, efficient planning for its improvement cannot be conducted, hence the CaS-POL registry initiative.

Who May Be Eligible (Plain English)

Who May Qualify: - Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E. - age \> 18 years old - persistent hemodynamic failure defined as systolic blood pressure of \<90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs Who Should NOT Join This Trial: - patients without return of spontaneous circulation who were considered to extracorporeal cardiopulmonary resuscitation (ECPR) - primary septic, anaphylactic, hypovolemic shock - post-operative cardiogenic shock - end-stage of heart failure disqualified from mechanical circulatory support and heart transplantation Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E. * age \> 18 years old * persistent hemodynamic failure defined as systolic blood pressure of \<90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs Exclusion Criteria: * patients without return of spontaneous circulation who were considered to extracorporeal cardiopulmonary resuscitation (ECPR) * primary septic, anaphylactic, hypovolemic shock * post-operative cardiogenic shock * end-stage of heart failure disqualified from mechanical circulatory support and heart transplantation

Locations (2)

Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland
Wroclaw, Lower Silesian Voivodeship, Poland
Wroclaw Medical University
Wroclaw, Poland